Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-23

Clinical Trial Update: Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pegaspargase-COEP chemotherapy with radiotherapy for extranodal NK/T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pegaspargase-COEP chemotherapy

Snippet

Sponsor: Peking University | Conditions: NK/T Cell Lymphoma Nos | Phase 2 | Status: UNKNOWN